title: The Views of Young Women on HPV Vaccine Communication in Four European Countries.
abstract: The Human Papilloma Virus (HPV) is the most common sexually transmitted infection (STI) and can cause cervical cancer. Two vaccines are available to protect against the most common strands of the virus. Vaccination programs differ across Europe but most neglect young adults, who are the group with the highest risk of contracting STIs. Our aim was to explore the views of young women from four European countries—Scotland, Spain, Serbia, and Bulgaria - about the HPV vaccine communication strategy. These countries are characterized by different cervical cancer prevalence and vaccine implementation policies. We conducted focus group discussions with young women (aged 18-26) with various vaccination histories in a purposive sample. We subjected the data to thematic analysis with the purpose of identifying themes related to communication about the HPV vaccine. We recorded the information sources mentioned by participants. Participants discussed numerous sources of vaccine-related information. They approached information critically rather than naively and questioned the sources' trustworthiness and motives. Participants desired transparent information about the risks of the virus and the risks and benefits of the vaccine. These risks and benefits were individualized in view of personal and external factors. Particular aspects of the vaccine and the way information was communicated resulted in feelings of uncertainty. There were notable cross-cultural differences in experiences with HPV vaccine communication. Our results suggest that transparent risk communication about the HPV vaccine is valued by young women. In addition, both individual and culturally-dependent factors influenced experiences with, and preference for information.
authors.affiliation: Centro de Investigación Mente, Cerebro y Comportamiento, Universidad de Granada, Campus Universitario de Cartuja s/n, 18071 Granada, Spain. dafinapetrova@ugr.es.
authors.forename: Dafina
authors.initials: D
authors.lastname: Petrova
authors.forename: Carol Gray
authors.initials: CG
authors.lastname: Brunton
authors.forename: Moritz
authors.initials: M
authors.lastname: Jaeger
authors.forename: Anita
authors.initials: A
authors.lastname: Lenneis
authors.forename: Rocio
authors.initials: R
authors.lastname: Munoz
authors.forename: Rocio
authors.initials: R
authors.lastname: Garcia-Retamero
authors.forename: Irina
authors.initials: I
authors.lastname: Todorova
mesh_terms: D000328:Adult; D002031:Bulgaria; D003142:Communication; D003431:Cross-Cultural Comparison; D005260:Female; D017144:Focus Groups; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D030361:Papillomavirus Infections / Q000150:complications / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D010353:Patient Education as Topic / Q000592:standards*; D036301:Qualitative Research; D012606:Scotland; D055771:Serbia; D013030:Spain; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control / Q000821:virology; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines